WallStreetZenWallStreetZen

NYSE: AACT
Ares Acquisition Corp Ii Stock

$10.57+0.00 (+0%)
Updated Mar 28, 2024
AACT Price
$10.57
Fair Value Price
N/A
Market Cap
$660.63M
52 Week Low
$10.05
52 Week High
$10.76
P/E
29.36x
P/B
-32.6x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$16.92M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.12
Operating Cash Flow
-$1M
Beta
0.01
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

Zen Score

–
Industry Average (7)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how AACT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

AACT is good value based on its earnings relative to its share price (29.36x), compared to the US market average (44.51x)
P/E vs Market Valuation
AACT is good value based on its earnings relative to its share price (29.36x), compared to the US Shell Companies industry average (43.11x)
P/E vs Industry Valuation
AACT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more AACT due diligence checks available for Premium users.

Be the first to know about important AACT news, forecast changes, insider trades & much more!

Valuation

AACT price to earnings (PE)

For valuing profitable companies with steady earnings
Company
29.36x
Industry
43.11x
Market
44.51x
AACT is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
AACT is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

AACT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-32.6x
Industry
-14.49x

AACT's financial health

Profit margin

Revenue
$0.0
Net Income
$6.9M
Profit Margin
0%
AACT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$525.5M
Liabilities
$22.8M
Debt to equity
-1.12
AACT's short-term assets ($2.42M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AACT's long-term liabilities ($22.50M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AACT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AACT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$264.4k
Investing
$0.0
Financing
-$85.0k
AACT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

AACT vs Shell Company Stocks

TickerMarket Cap1d %P/EP/B
AACT$660.63M+0.05%29.36x-32.60x
BCSA$586.40M0.00%123.33x-30.88x
ALCC$492.21M+2.42%60.11x-29.41x
SLAM$441.97M+1.37%55.65x-12.81x
ANSC$437.93M-0.15%92.32x-36.09x

Ares Acquisition Ii Stock FAQ

What is Ares Acquisition Ii's quote symbol?

(NYSE: AACT) Ares Acquisition Ii trades on the NYSE under the ticker symbol AACT. Ares Acquisition Ii stock quotes can also be displayed as NYSE: AACT.

If you're new to stock investing, here's how to buy Ares Acquisition Ii stock.

What is the 52 week high and low for Ares Acquisition Ii (NYSE: AACT)?

(NYSE: AACT) Ares Acquisition Ii's 52-week high was $10.76, and its 52-week low was $10.05. It is currently -1.72% from its 52-week high and 5.17% from its 52-week low.

How much is Ares Acquisition Ii's stock price per share?

(NYSE: AACT) Ares Acquisition Ii stock price per share is $10.57 today (as of Mar 28, 2024).

What is Ares Acquisition Ii's Market Cap?

(NYSE: AACT) Ares Acquisition Ii's market cap is $660.63M, as of Mar 29, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Ares Acquisition Ii's market cap is calculated by multiplying AACT's current stock price of $10.57 by AACT's total outstanding shares of 62,500,000.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.